What is RYAM?
RYAM operates at the intersection of industrial manufacturing and sustainable innovation, specializing in the production of high-purity cellulose specialties. These natural polymers serve as critical components across a diverse array of sectors, including pharmaceuticals, food production, and advanced filtration systems. Beyond its core cellulose offerings, the company utilizes its specialized asset base to drive the production of biofuels, bioelectricity, and other essential biomaterials such as bioethanol and tall oils.
As a key player in the bioeconomy, RYAM maintains a competitive advantage through its proprietary technology and global supply chain. The company's commitment to high-purity standards ensures its products remain indispensable to industrial clients seeking sustainable alternatives to traditional chemical inputs. This market position is further bolstered by a strategic focus on ESG-compliant production methods, aligning the company with the global shift toward renewable industrial resources.
How much funding has RYAM raised?
RYAM has raised a total of $70.5M across 2 funding rounds:
Private Equity
$31.6M
Debt
$39M
Private Equity (2024): $31.6M with participation from SWEN Capital Partners
Debt (2024): $39M led by Arkéa Banque Entreprises et Institutionnels, SWEN Capital Partners, BNP Paribas, and Lcl
Key Investors in RYAM
SWEN Capital Partners
SWEN Capital Partners is a responsible investor specializing in private equity, infrastructure, and private debt, focused on creating sustainable value through Tech for Good and Climate Impact initiatives.
BNP Paribas
BNP Paribas is a leading international banking group providing comprehensive financing, advisory, and capital markets solutions, with a strong commitment to supporting energy transition and sustainable finance.
Arkéa Banque Entreprises et Institutionnels
Arkéa Banque Entreprises et Institutionnels is a specialized financial services provider based in France, focusing on corporate and institutional banking solutions.
What's next for RYAM?
Looking ahead, the strategic deployment of this recent capital will likely focus on optimizing production efficiency and expanding the company's portfolio of bio-based products. Given the current enterprise-level funding context, RYAM is expected to prioritize the scaling of its bio-refinery operations to meet the rising global demand for sustainable energy and materials. The integration of these funds will support ongoing research and development initiatives aimed at enhancing the yield and purity of its cellulose-based outputs, ensuring the company remains at the forefront of the green industrial revolution. Furthermore, the involvement of major financial institutions suggests a robust framework for future capital allocation and potential expansion into emerging markets for bio-derived industrial applications.
See full RYAM company page
